Condition: Uterine Cervical Neoplasm · Uterine Cervical Dysplasia · Human Papilloma Virus · Sponsor: Universiteit Antwerpen
The goal of the COMBISCREEN project is to develop a fully molecular cervical screening and triage approach that is applicable on self-samples, which are an easily accessible and non-invasive source of biomarkers. The project allows a one-step screening and triage modality and thereby identifies women with clinically relevant disease that are in need of treatment.
This description comes directly from the study's public registry record.
Alex Vorsters, Ir, PhD · 032659130 · alex.vorsters@uantwerpen.be
Eef van den Borst, MSc · 032652665 · eef.vandenborst@uantwerpen.be
Always discuss trial participation with your own doctor first.
| Universitair Ziekenhuis Antwerpen (UZA) | Edegem, Antwerpen, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06598176